There is an interesting article in this week’s BMJ regarding a letter that was written to the Times by various doctors warning against generic drugs and supporting branded ones. This letter was in response to a recent DH consultation on prescribing generics. However, it seems that this article was spearheaded by a small pharmaceutical company Norgine although conflicts of interest were not stated within the letter.

Read more at BMJ, 2010. 340 (7747), pp627.